|
Rat Strains:
|
Clinical Measurements:
|
Experimental Conditions:
|
Measurement Methods:
|
|
|
|
Options: | View chart | | | Download data table | | | View expanded data table |
# | Reference Title | Reference Citation |
1. | Chromosomal mapping of a major quantitative trait locus regulating compensatory renal growth in the rat. | Pravenec M, etal., J Am Soc Nephrol 2000 Jul;11(7):1261-5 |
2. | RGD Strain RSO annotation pipeline | RGD Automated Pipelines |
3. | Metabolic characterization of insulin resistance syndrome feature loci in three brown Norway-derived congenic strains. | Seda O, etal., Folia Biol (Praha) 2002;48(3):81-8. |
4. | Rosiglitazone improves insulin resistance, lipid profile and promotes adiposity in a genetic model of metabolic syndrome X. | Seda O, etal., Folia Biol (Praha) 2002;48(6):237-41. |
5. | Differential linkage of triglyceride and glucose levels on rat chromosome 4 in two segregating rat populations. | Seda O, etal., Folia Biol (Praha). 2003;49(6):223-6. |
6. | A 14-gene region of rat chromosome 8 in SHR-derived polydactylous congenic substrain affects muscle-specific insulin resistance, dyslipidaemia and visceral adiposity. | Seda O, etal., Folia Biol (Praha). 2005;51(3):53-61. |
7. | Dynamic genetic architecture of metabolic syndrome attributes in the rat. | Seda O, etal., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
8. | Novel double-congenic strain reveals effects of spontaneously hypertensive rat chromosome 2 on specific lipoprotein subfractions and adiposity. | Seda O, etal., Physiol Genomics. 2006 Jul 5;. |
9. | Rat inbred PD/cub strain as a model of dyslipidemia and insulin resistance. | Sedova L, etal., Folia Biol (Praha) 2000;46(3):99-106. |
10. | Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome. | Sedova L, etal., Int J Obes Relat Metab Disord. 2004 May;28(5):719-25. |
Symbol | Name | Trait |
Bw63 | Body weight QTL 63 |
body mass (VT:0001259)
|
Bw64 | Body weight QTL 64 |
body mass (VT:0001259)
|
Bw65 | Body weight QTL 65 |
body mass (VT:0001259)
|
Bw66 | Body weight QTL 66 |
body mass (VT:0001259)
|
Bw67 | Body weight QTL 67 |
body mass (VT:0001259)
|
Bw68 | Body weight QTL 68 |
body mass (VT:0001259)
|
Bw69 | Body weight QTL 69 |
body mass (VT:0001259)
|
Bw70 | Body weight QTL 70 |
body mass (VT:0001259)
|
Bw71 | Body weight QTL 71 |
body mass (VT:0001259)
|
Bw72 | Body weight QTL 72 |
body mass (VT:0001259)
|
Bw73 | Body weight QTL 73 |
body mass (VT:0001259)
|
Bw74 | Body weight QTL 74 |
body mass (VT:0001259)
|
Bw75 | Body weight QTL 75 |
body mass (VT:0001259)
|
Bw76 | Body weight QTL 76 |
body mass (VT:0001259)
|
Bw77 | Body weight QTL 77 |
epididymal fat pad mass (VT:0010421)
|
Bw78 | Body weight QTL 78 |
epididymal fat pad mass (VT:0010421)
|
Bw79 | Body weight QTL 79 |
epididymal fat pad mass (VT:0010421)
|
Cm60 | Cardiac mass QTL 60 |
heart mass (VT:0007028)
|
Epfw1 | Epididymal fat weight QTL 1 |
epididymal fat pad mass (VT:0010421)
|
Epfw2 | Epididymal fat weight QTL 2 |
epididymal fat pad mass (VT:0010421)
|
Epfw3 | Epididymal fat weight QTL 3 |
epididymal fat pad mass (VT:0010421)
|
Epfw4 | Epididymal fat weight QTL 4 |
epididymal fat pad mass (VT:0010421)
|
Gluco18 | Glucose level QTL 18 |
blood glucose amount (VT:0000188)
|
Gluco19 | Glucose level QTL 19 |
blood glucose amount (VT:0000188)
|
Gluco20 | Glucose level QTL 20 |
blood glucose amount (VT:0000188)
|
Gluco21 | Glucose level QTL 21 |
blood glucose amount (VT:0000188)
|
Gluco22 | Glucose level QTL 22 |
blood glucose amount (VT:0000188)
|
Gluco23 | Glucose level QTL 23 |
blood glucose amount (VT:0000188)
|
Gluco24 | Glucose level QTL 24 |
blood glucose amount (VT:0000188)
|
Gluco25 | Glucose level QTL 25 |
blood glucose amount (VT:0000188)
|
Gluco26 | Glucose level QTL 26 |
blood glucose amount (VT:0000188)
|
Gluco27 | Glucose level QTL 27 |
blood glucose amount (VT:0000188)
|
Gluco28 | Glucose level QTL 28 |
blood glucose amount (VT:0000188)
|
Gluco29 | Glucose level QTL 29 |
blood glucose amount (VT:0000188)
|
Gluco30 | Glucose level QTL 30 |
blood glucose amount (VT:0000188)
|
Insul10 | Insulin level QTL 10 |
blood insulin amount (VT:0001560)
|
Insul5 | Insulin level QTL 5 |
blood insulin amount (VT:0001560)
|
Insul6 | Insulin level QTL 6 |
blood insulin amount (VT:0001560)
|
Insul7 | Insulin level QTL 7 |
blood insulin amount (VT:0001560)
|
Insul8 | Insulin level QTL 8 |
blood insulin amount (VT:0001560)
|
Insul9 | Insulin level QTL 9 |
blood insulin amount (VT:0001560)
|
Kidm30 | Kidney mass QTL 30 |
kidney mass (VT:0002707)
|
Kidm31 | Kidney mass QTL 31 |
kidney mass (VT:0002707)
|
Kidm32 | Kidney mass QTL 32 |
kidney mass (VT:0002707)
|
Kidm33 | Kidney mass QTL 33 |
kidney mass (VT:0002707)
|
Kidm34 | Kidney mass QTL 34 |
kidney mass (VT:0002707)
|
Livw1 | Liver weight QTL 1 |
liver mass (VT:0003402)
|
Livw2 | Liver weight QTL 2 |
liver mass (VT:0003402)
|
Sffal1 | Serum free fatty acids level QTL 1 |
blood free fatty acid amount (VT:0001553)
|
Sffal2 | Serum free fatty acids level QTL 2 |
blood free fatty acid amount (VT:0001553)
|
Stl20 | Serum triglyceride level QTL 20 |
blood triglyceride amount (VT:0002644)
|
Stl21 | Serum triglyceride level QTL 21 |
blood triglyceride amount (VT:0002644)
|
Sual1 | Serum uric acid level QTL 1 |
blood uric acid amount (VT:0010302)
|
Note Type | Note | Reference |
---|---|---|
strain_drgs_chems | Fenofibrate (100mg/kg/day) displayed an increase in adiposity and lowered the triglycerides | 1580750 |
strain_drgs_chems | Isotretinoin (30mg/kg/day) displayed increase in adiposity and triglycerides. | 1580750 |
strain_phys_biochem | Carries genes involved in lipid and carbohydrate metabolism. | 632347 |